Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CRISPR Therapeutics AG CRSP

Set alert

Price alert · CRSP

All alert types
49.99 USD -1.43 -2.78%

At close

50.02 +0.03 +0.06%

Pre-market · Nov 3, 8:00 AM ET

Bid
49.96 × 1
Ask
50.01 × 1
49.70 Day range 52.12
44.12 52-week range 63.45
YTD
-4.67%
1 year
-19.33%
Open
51.90
Prev close
51.42
Mkt cap
4.83B
Vol
1.03M
Avg vol
1.53M
EPS
-4.74
P/E
0.00
Div yield
0.00%
More statistics
Low
49.70
High
52.12
Forward P/E
-14.07
Beta
1.90
Short ratio
9.18
Inst. own
79.75%
Dividend
0.00
Ex-div date
Earnings
Feb 16, 2027
50-d avg
54.19
200-d avg
52.88
1y target
85.63

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 4, 2026Earnings: -1.28; estimate -1.18964; surprise -7.6%
  • Aug 3, 2026Earnings: -0.94; estimate -1.19; surprise 21.01%
  • Aug 4, 2026Rating: Citigroup · Buy → Buy
  • Nov 2, 2026Earnings: -1.15; estimate -1.04; surprise -10.58%
Signals (54)
NameDateAgo
SMA: BearishNov 2, 202616 hours ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishAug 1, 20263 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BearishJan 1, 202610 months ago
SMA: BullishJul 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
SMA: BullishJun 1, 20251 year ago
MACD: Sell SignalSep 1, 20242 years ago
SMA: BearishAug 1, 20242 years ago
SMA: BullishJul 1, 20242 years ago

Newest 20 of 54.

Analyst view

Consensus: buy

Buy
Price target (mean) 85.63 +71.3% upside
Target (low)
44.00
Target (mean)
85.63
Target (high)
291.00
Ratings (0m) 23 13 buy · 10 hold · 0 sell
  • Strong buy4
  • Buy9
  • Hold10
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 23
  • 1 month ago 22
  • 2 months ago 22

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CRSP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.06-1.50 – -0.46-1.17+9.4%16.56M+1763.3%17
Next quarter-1.16-2.02 – -0.51-1.37+15.2%17.43M+1917.2%17
Current year-4.45-5.84 – -3.19-6.47+31.3%40.44M+1052.1%19
Next year-3.55-5.40 – -0.51-4.45+20.1%153.97M+280.8%19

Upgrades and downgrades

The latest rating changes

CRSP analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026UBSInitiated—Neutral
Aug 31, 2026CitizensReiteratedMarket OutperformMarket Outperform
Aug 31, 2026NeedhamReiteratedBuyBuy
Aug 25, 2026CitizensReiteratedMarket OutperformMarket Outperform
Aug 4, 2026CitigroupMaintainedBuyBuy
Jul 8, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 6, 2026CitizensReiteratedMarket OutperformMarket Outperform
May 13, 2026BernsteinMaintainedMarket PerformMarket Perform
May 6, 2026CitigroupMaintainedBuyBuy
Mar 17, 2026Piper SandlerReiteratedOverweightOverweight
Feb 17, 2026Chardan CapitalMaintainedBuyBuy
Feb 13, 2026TD CowenMaintainedHoldHold
Feb 13, 2026Evercore ISI GroupMaintainedOutperformOutperform
Feb 13, 2026NeedhamMaintainedBuyBuy
Jan 30, 2026CitizensMaintainedMarket OutperformMarket Outperform
Dec 23, 2025NeedhamReiteratedBuyBuy
Dec 23, 2025CitizensReiteratedMarket OutperformMarket Outperform
Nov 26, 2025Chardan CapitalMaintainedBuyBuy
Nov 12, 2025CitigroupMaintainedBuyBuy
Nov 11, 2025RBC CapitalMaintainedSector PerformSector Perform
Nov 11, 2025BairdMaintainedNeutralNeutral
Nov 10, 2025NeedhamMaintainedBuyBuy
Oct 17, 2025B of A SecuritiesMaintainedBuyBuy
Oct 10, 2025NeedhamReiteratedBuyBuy
Sep 23, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 18, 2025JP MorganInitiated—Overweight
Aug 7, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 6, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Aug 5, 2025Chardan CapitalMaintainedBuyBuy
Aug 5, 2025RBC CapitalMaintainedSector PerformSector Perform